1Davidson B.Malignant effusions:from diagnosis to biology[J].Diagn Cytopathol,2004,31:246-254
2Yeoh GP,Chan KW,Lander I,et al.Evaluation of the thinPrep Papanicolaou test in clinical practice:6-month study of 16541 cases with histological correlation in 220 cases[J].Hong Kong Med J,1999,5:233-239
3Michael CW,Hunter B.Interpretation of FNA processed by the thinPrep technique:cytologic artifacts and diagnostic pitfalls[J].Diagn Cytopathol,2000,23:6-13
5Alvarez RD,To A,Boots LR,et al.CA125 as a serum maker for poor prognosis in ovarian malignancies[J].Gynecol Oncol,1987,26:284-289
6Chan KK,Selman TJ.Testing for ovarian cancer[J].Best Pract Res Clin Obstet Gynaecol,2006,20:977-983
7Gadducci A,Cosio S,Zola P,et al.Surveillance procedures for patients treated for epithelial ovarian cancer:a review of the literature[J].Int J Gynecol Cancer,2007,17:21-31
4Passebosc - FaureK, LiG, LambertC et al. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions [J]. Clin Cancer Res, 2005, 11 (9): 6862.
6Takeshima N, Nishida H, Tabata T et al. Positive peritoneal cytology in endometrial carcer: enhancement of other prognostic in dicatorsJ[J]. Gynecol Oncol, 2001, 82 (3): 470.
7Aniali Limaye. Comparative analysis of conventional Papanieolaou tests and a fluid thin - based thin - layer method [ J ] . Arch Pathol Lab Med, 2003, 127 (2): 143.
8Michael CW, Hunter B. Interpretation of FNA processed by the Thinprep technique: Cytologic artifacts and diagnostic pitfalls [J ] . Diagn Cytopathol, 2000, 23:6 -13.
9Hunter B, Michael CW. Cytologic artifacts and pitfalls in fine needle aspirates processed by Thinprep technique [ J] . Acta Cytol, 1998, 42: 1220.
10Passebosc - FaureK, Li G, Lambert C, et al. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions [J].Clin Cancer Res, 2005, 11(9) : 6862.
